Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 11/21/2024 | $145.00 → $160.00 | Overweight | Barclays | |
| 11/21/2024 | $155.00 → $170.00 | Overweight | Analyst | |
| 11/21/2024 | $150.00 → $165.00 | Buy | Goldman | |
| 11/21/2024 | $165.00 → $185.00 | Overweight | Wells Fargo | |
| 11/21/2024 | $167.00 → $169.00 | Buy | Truist | |
| 11/21/2024 | $150.00 → $190.00 | Outperform | Robert W. Baird | |
| 11/21/2024 | $170.00 → $190.00 | Buy | The Benchmark Company | |
| 11/21/2024 | $189.00 → $190.00 | Outperform | Evercore ISI |
4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G/A - C3.ai, Inc. (0001577526) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
4 - C3.ai, Inc. (0001577526) (Issuer)
4 - Hims & Hers Health, Inc. (0001773751) (Issuer)
4 - Tesla, Inc. (0001318605) (Issuer)
Former FDA deputy commissioner and former Pfizer & Hillrom quality executive join Hims & Hers, deepening the leadership that drives the company's high standard of quality and safety Hims & Hers Health, Inc. ("Hims & Hers") (NYSE:HIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, will join the company's board of directors, and Janet Stevens, a pharmaceutical quality expert, will join the company as Global Head of Quality & Safety. Hims & Hers continues to prioritize safety across its platform, offerings, and leadership so that every customer can have the confidence that the solutions they have access to are safe, high-quality,
NEW YORK, Nov. 1, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) and Dow Jones Utility Average (DJUA) effective prior to the open of trading on Friday, November 8: NVIDIA Corp. (NASD:NVDA) will replace Intel Corp. (NASD:INTC), and The Sherwin-Williams Co. (NYSE:SHW) will replace Dow Inc. (NYSE:DOW) in the Dow Jones Industrial Average. The index changes were initiated to ensure a more representative exposure to the semiconductors industry and the materials sector respectively. The DJIA is a price weighted index, and thus persistently lower priced stocks have a minimal impact on the index. Dow Inc. is also the smallest com
BOISE, Idaho, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) today announced that Robert (Bob) Switz, its current Board Chair, will retire at the annual shareholders meeting on Jan. 16, 2025. The Board has unanimously approved the appointment of Micron's President and CEO, Sanjay Mehrotra, to serve as Board Chair and Lynn Dugle as Lead Independent Director following the annual shareholders meeting. Switz joined Micron's Board of Directors in 2006 and was named Chair in 2012. With broad experience, a clear-headed approach and exceptional business acumen, Switz has been a leading voice in driving strong governance and the company's successful strategy. Throughout his
To gain an edge, this is what you need to know today. GDP Brings Buying Please click here for an enlarged chart of Invesco QQQ Trust Series 1 (NASDAQ:QQQ). Note the following: The chart shows a drop in QQQ. The drop in QQQ was triggered by speculative sentiment pulling back. As a reader of The Arora Report, you knew in advance that speculative sentiment could fall as a result of Tesla Inc (NASDAQ:TSLA) earnings. The chart shows that QQQ is approaching the support zone. RSI on the chart shows that QQQ is now oversold. Oversold markets tend to bounce. The chart shows that the volume was low on the selloff. This indicates a lack of conviction in selling. Especially hard hit in
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Baird increased Apple Inc. (NASDAQ:AAPL) price target from $200 to $240. Baird analyst William Power maintained an Outperform rating. Apple shares fell 0.1% to trade at $218.51 on Thursday. See how other analysts view this stock. Truist Securities raised the price target for ServiceNow, Inc. (NYSE:NOW) from $750 to $780. Truist Securities analyst Joel Fishbein maintained a Hold rating. ServiceNow shares gained 11.9% to trade at $817.75 on Thursday. See how other analysts view this stock. JP Morg
Honda Motor Co. (NYSE:HMC) will reduce its production of gasoline vehicles in China by 19% starting this October, marking a strategic shift toward electric vehicles. The Japanese automaker will cease operations of one production line at its joint venture Dongfeng Honda, which has an annual capacity of 240,000 units, beginning in November. Additionally, in October, GAC Honda, another of its facilities with a capacity of 50,000 units annually, will be completely shut down. These changes are part of Honda's effort to accelerate the “steady shift” to EVs, reported Bloomberg. Honda’s production capacity in China, currently around 1.5 million units, will see a reduction of 19% due to
Barclays reiterated coverage of NVIDIA with a rating of Overweight and set a new price target of $160.00 from $145.00 previously
Analyst reiterated coverage of NVIDIA with a rating of Overweight and set a new price target of $170.00 from $155.00 previously
Goldman reiterated coverage of NVIDIA with a rating of Buy and set a new price target of $165.00 from $150.00 previously
SANTA CLARA, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- NVIDIA will present at the following events for the financial community: UBS Global Technology and AI ConferenceTuesday, Dec. 3, 6:35 a.m. Pacific time J.P. Morgan Healthcare ConferenceMonday, Jan. 13, 9:45 a.m. Pacific time Interested parties can listen to the live audio webcast of NVIDIA financial presentations at investor.nvidia.com. Webcast replays are available for 90 days afterward. About NVIDIANVIDIA (NASDAQ:NVDA) is the world leader in accelerated computing. For further information, contact: NVIDIA Investor RelationsNVIDIA Corporate [email protected]@nvidia.com © 2024 NVIDIA Corporation. All rights reserv
BOISE, Idaho, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) announced today that it will hold its fiscal first quarter earnings conference call on Wednesday, Dec. 18, 2024, at 2:30 p.m. Mountain time. The call will be webcast live at http://investors.micron.com/. Webcast replays of presentations can be accessed from Micron's Investor Relations website for approximately one year after the call. About Micron Technology, Inc. We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership, and manufacturing and operational excellenc
Continuing to strengthen its comprehensive weight loss offerings, Hims & Hers' addition of daily meal replacement bars and shakes is the company's latest step in helping its customers reach – and maintain – their health and wellness goals Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that Hims & Hers customers will now be able to supplement their treatment plan with daily meal replacement bars and shakes to support them on their comprehensive weight loss journey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241121849741/en/To help its customers stay on top of
BOISE, Idaho, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ:MU) announced today that it will hold its fiscal first quarter earnings conference call on Wednesday, Dec. 18, 2024, at 2:30 p.m. Mountain time. The call will be webcast live at http://investors.micron.com/. Webcast replays of presentations can be accessed from Micron's Investor Relations website for approximately one year after the call. About Micron Technology, Inc. We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all. With a relentless focus on our customers, technology leadership, and manufacturing and operational excellenc
Record quarterly revenue of $35.1 billion, up 17% from Q2 and up 94% from a year agoRecord quarterly Data Center revenue of $30.8 billion, up 17% from Q2 and up 112% from a year ago SANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ:NVDA) today reported revenue for the third quarter ended October 27, 2024, of $35.1 billion, up 17% from the previous quarter and up 94% from a year ago. For the quarter, GAAP earnings per diluted share was $0.78, up 16% from the previous quarter and up 111% from a year ago. Non-GAAP earnings per diluted share was $0.81, up 19% from the previous quarter and up 103% from a year ago. "The age of AI is in full steam, propelling a global
Revenue growth of 22% year-over-year Net income of $5.4 million and non-GAAP net income of $25.3 million Net income margin of 2%; Adjusted EBITDA margin of 40% LEHI, Utah and LOUISVILLE, Ky., Nov. 6, 2024 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the three-month period ended September 30, 2024. "Waystar delivered another quarter of strong top-line growth," said Matt Hawkins, Chief Executive Officer of Waystar. "Our revenue reached $240 million, representing 22% year-over-year growth, an a
8-K - Hims & Hers Health, Inc. (0001773751) (Filer)
10-Q - NVIDIA CORP (0001045810) (Filer)
8-K - NVIDIA CORP (0001045810) (Filer)
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea
For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal